Meanwhile! Back at in London, @Fran_Rawlins gave a brilliant presentation showcasing TRANSFORM at the @ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening @ImperialSandC @ProstateUK @LondonProstate1

The trial is led by researchers @ImperialNHS and @imperialcollege with @ucl, @QMUL and @ICR_London. Backed by @ProstateUK, it is the biggest and most ambitious prostate cancer trial in 20 years that aims to transform diagnosis and reduce prostate cancer deaths by up to 40%. 2/2

Prostate cancer is now the most commonly diagnosed cancer in England according to an analysis by @ProstateUK. This #WorldCancerDay, we want to shine a light on the TRANSFORM trial which is looking to find the best way to screen for prostate cancer ➡️ https://t.co/StknliQEkh 1/2

Fine balance of savings lives & harms of screening for prostate cancer “…we have not shown enough risk mitigation yet to justify a national screening programme.” Which is why @ProstateUK & @NIHRresearch funded £42M TRANSFORM study https://t.co/Ve5Jfyy6lb

Congratulations #IP7PACIFIC - 8️⃣6️⃣5️⃣ patients recruited so far! ⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies to detect prostate cancer 🔗 https://t.co/bZwzpHEelK #UrSoMe #prostatecancer #prostatecancerdiagnosis #bpMRI

[7/7] Prostate Cancer UK are proud to have launched the £42m TRANSFORM trial to find the best way to screen for prostate cancer, so one day all men at risk are invited for regular tests to find aggressive prostate cancer in time for a cure. https://t.co/wGNYIVvLzc

It’s a complete disgrace. There has to be accountability. This is daily. Who is actually listening to this @thameswater @LondonPortAuth @LBC

We're proud to announce that #OurImperial Professor Hashim Ahmed [@LondonProstate1] and Professor Rakesh Heer are two of the six lead researchers on @ProstateCancerUK's £42 million TRANSFORM screening trial. TRANSFORM is the biggest and most ambitious prostate cancer trial in 20

We are ✨incredibly proud✨ to be leading the #TRANSFORM prostate cancer screening trial in collaboration with our colleagues from @ucl @QMUL @ICR_London @royalmarsdenNHS @imperialcollege supported by @ProstateUK @NIHRresearch @MovemberUK

Well done everyone. What a team! Very proud of every single one of them. #ipmasterclass24

Thanks to our enthusiastic chairs @AJWLight and Mr Arnas Rakauskas. Onto our final plenary session of Day 1: Prostate Biopsy, chaired by @johannboaz and @Fran_Rawlins.

🧵@ImperialNHS has been awarded £3m by @NIHRresearch for a new HealthTech Research Centre, led by S&C's @profgeorgehanna, to support the development & evaluation of new diagnostic innovations for cancer, infectious & respiratory diseases, critical care, & primary and social care.

🎉 What a fantastic way to end the year at the @ImperialSandC Awards! Congratulations to everyone at @IP_London for their dedication and hard work in 2023! @imperialurology @imperialcollege @ImperialNHS

Team @IP_London at #BAUS23! @LondonProstate1 @TaimurShah @Connor_Urol @Fran_Rawlins @NikhilMayor @AJWLight

🔬 Tomorrow (20/05) is #InternationalClinicalTrialsDay 🔬 Thank you to our hard working multi-disciplinary research team - and most importantly our patient participants! 🔬 Take a look at #ImperialProstate clinical trials past & present @ https://t.co/wcuHaBDVcC

Great milestone! This RCT will answer the key question of mpMRI vs bpMRI for prostate cancer detection @LondonProstate1 @ProfPadhani @andrea_rockall @Heer_Lab

I hear at 30 now! Whilst paired cohort studies might show non-inferiority, how will radiologists score, and urologists use, a biparametric MRI when that’s all they have? #IP7PACIFIC is the only pivotal non-inferiority RCT of bpMRI vs. mpMRI

⏱️ #IP7PACIFIC is now recruiting at @ImperialNHS! ⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies for the detection of prostate cancer 🔗 https://t.co/GNMnCuCEbO @LondonProstate1 @Fran_Rawlins @imperialurology @CR_UK @SU2CUK #UrSoMe #prostatecancer

I am humbled to be surrounded by such an enthusiastic and energetic young team. We are all very proud of them. @imperialurology @IP_London @ImperialSandC #ipmasterclass22 @BAUSurology

Excellent achievement for the whole team at Imperial Prostate and the ReIMAGINE consortium